
HBOT has proven to be very effective before and after any type of stem cell based treatments. Its high degree of safety in current methods provides a potential for augmenting the success of such procedures. Exposure to hyperbaric oxygen therapy (HBOT) can cause rapid stem cell mobilization in peripheral circulation. The same occurs with our own bone marrow stem cells when they are exposed to pressurization. The results from flow cytometry in stem cells exposed to HBO therapy have shown high regeneration responses, so therefore high levels of oxygen molecules in body fluids and blood stream can result in better stem cell response.
Human Placenta holds great potential for stem cell based therapies and regenerative medicine. Human placenta is a rich source of stem cells and large volumes of placenta tissue can provide abundant numbers of primary stem cells with a high capacity for differentiating in to all tissue types in the human body. Lyophilized Human Placenta based therapy is one of the most promising treatments in modern medicine. A variety of diseases can potentially be cured because of this treatment by enhancing and extending patient’s lives.
Augments blood circulation, balance cells nutrition, repairs the endothelial system (which is the main precursor of high blood pressure), reverse premature aging (anti-aging precursor), reverse the andropause and menopause, regenerates damaged tissue originated by illnesses, injuries or aging, fight back cell oxidation, restores health, strength and vitality.
Lyophilized Human Placenta has also successfully been used in aesthetic medicine. It can also be used for a number of applications such as restoring damaged skin or for recovering tissue elasticity.
Lyophilized Human Placenta stimulates Insulin Growth Factor (IGF-1) which is synthetized in placenta, kidneys, heart, liver, pancreas, lungs, spleen, intestine, ovaries, cerebrum, bone marrow and hyphophysis (which start decreasing after the 30’s and it is directly responsible for gradually aging)